What is the recommended treatment for complex regional pain syndrome (CRPS)?

Treatment of Complex Regional Pain Syndrome (CRPS)

CRPS requires a multimodal treatment approach starting with physical rehabilitation and pharmacologic management, progressing to interventional procedures including sympathetic nerve blocks and spinal cord stimulation for refractory cases, with treatment selection guided by the predominant pathophysiological subtype (inflammatory, nociplastic/neuropathic, vasomotor, or motor). 1

Initial Management Framework

Physical Rehabilitation (First-Line)

• Progressive physical and occupational therapy should be initiated immediately upon diagnosis, as early aggressive management improves long-term outcomes. 2
• Rehabilitation includes progressive tactile stimulation (desensitization), normalization of movement patterns to prevent range-of-motion limitations, and graded motor imagery. 2
• When pain severity prevents participation in rehabilitation, escalate to interventional procedures to enable physical therapy engagement. 2

Pharmacologic Management by Subtype

Inflammatory Subtype:

• Bisphosphonates are effective for treating the inflammatory subtype of CRPS. 1
• Corticosteroids can be helpful, particularly in early-stage CRPS. 2
• NSAIDs may provide symptomatic relief, though evidence is extrapolated from general chronic pain guidelines. 3

Nociplastic/Neuropathic Subtype:

• Ketamine provides pain relief for the nociplastic/neuropathic subtype. 1
• Gabapentin and other anticonvulsants (particularly α-2-delta calcium-channel antagonists like pregabalin) are supported for neuropathic pain management. 3, 2
• Tricyclic antidepressants and serotonin-norepinephrine reuptake inhibitors have evidence for neuropathic pain conditions. 2
• Note: No FDA-approved medications exist specifically for CRPS; all pharmacologic treatments are off-label. 2

Vasomotor Subtype:

• Sympathetic nerve blocks are effective for addressing vasomotor disturbances. 1

Motor Subtype:

• Intrathecal baclofen may benefit end-stage motor disturbances. 1

Interventional Treatment Algorithm

First-Line Interventional Procedures

Sympathetic Nerve Blocks:

• Stellate ganglion blocks are first-line interventional treatment for upper extremity CRPS. 4
• Lumbar sympathetic blocks are first-line interventional treatment for lower extremity CRPS. 4
• Both fluoroscopic and ultrasound-guided approaches are available for stellate ganglion blockade. 4
• These blocks should be considered to support diagnosis of sympathetically maintained pain. 3

Advanced Neuromodulation (For Refractory Cases)

Spinal Cord Stimulation:

• Spinal cord stimulation may be considered for CRPS patients who have not responded to other therapies. 3
• A trial of spinal cord stimulation should be performed before permanent implantation. 3
• Shared decision-making must include specific discussion of potential complications associated with device placement. 3
• Neurostimulation is viable for refractory symptoms due to its multimechanistic properties effective across all CRPS subtypes. 1
• Novel approaches include new waveforms with dorsal column stimulation and dorsal root ganglion stimulation. 4

Peripheral Nerve Stimulation:

• Subcutaneous peripheral nerve stimulation may be used in multimodal treatment for painful peripheral nerve injuries unresponsive to other therapies. 3

Adjunctive Neuromodulation

TENS (Transcutaneous Electrical Nerve Stimulation):

• TENS should be used as part of multimodal pain management for chronic pain conditions. 3

Intrathecal Therapies

• Intrathecal opioid injection or infusion may be used for neuropathic pain in CRPS patients. 3
• Shared decision-making must include discussion of potential complications. 3
• Intrathecal neurolytic blocks should NOT be performed in routine non-cancer pain management. 3

Critical Diagnostic Considerations

Common Pitfall - Misdiagnosis:

• In 33% of patients labeled with CRPS type I, an identifiable nerve injury was present, suggesting misdiagnosis. 5
• Potentially treatable peripheral nerve injuries should be identified and addressed before confirming CRPS diagnosis. 5
• The Budapest criteria are applied inconsistently, with only 26% of patients having formal criteria assessment before specialist referral. 5
• Chronic CRPS (>12 months duration) requires specific diagnostic criteria including musculoskeletal dystrophy, neurogenic inflammation, and sympathetic dysfunction features. 6

Treatment Progression Strategy

Stepwise Escalation:

1. Immediate initiation of physical/occupational therapy with pharmacologic management based on predominant subtype 1, 2
2. If conservative treatment insufficient within weeks to months, proceed to sympathetic nerve blocks 1, 4
3. For persistent symptoms despite blocks, consider spinal cord stimulation trial 3, 1
4. Reserve intrathecal therapies and advanced neuromodulation for truly refractory cases 3

Key Principle: The effectiveness of treatment varies significantly between patients, requiring gradual progression through treatment options based on response and underlying pathophysiological subtype. 1